{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:24:28Z","timestamp":1795094668113,"version":"4.10.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The Drug User Liberation Front led an evaluation of a non-medicalized model of safer supply known as a \u201cCompassion Club.\u201d This club sourced, rigorously tested, packaged, and accurately labeled certain illicit substances and then provided them to club members at cost in order to investigate the effects and feasibility of a non-medical model of safer supply. Operating for 14 months, the club provided low-cost, quality-controlled illicit substances to individuals at risk of fatal overdose in Vancouver, Canada\u2019s Downtown Eastside neighbourhood. This study was undertaken to explore perceived impacts of the Compassion Club among its participants, as well as their perceptions regarding how the Club could be improved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>At the one-year time point of club operations 43 participants from the club\u2019s membership completed an interviewer-administered survey which is utilized in this cross sectional analysis. Descriptive statistics were employed to assess the perceived influence of club membership on various factors, including drug use patterns, harm reduction practices, financial outcomes, housing stability, and overall well-being.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Applicable responses reported benefits from membership in the Compassion Club, including reduced drug use (64.3%), decreased reliance on illicit markets (86.7%), lowered risk of overdose (90.0%), and increased likelihood of using sterile equipment (84.6%). Mental health (74.2%), physical health (63.3%), and overall well-being (70.0%) were also noted improvements. Suggestions for club improvement included extended operating hours, broader substance selection, and improved accessibility.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The reported reductions in drug use and improved adherence to harm reduction practices described herein underscore the perceived benefits of this unique program. Compassion Clubs represent a distinct strategy to mitigate overdose risk and enhance the well-being of drug users. These insights advance ongoing dialogues on overdose prevention strategies, urging further research to refine non-medicalized approaches within the evolving landscape of interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13011-025-00642-0","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:58:36Z","timestamp":1741597116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Perceived impacts of North Americas first de-medicalized safer supply program"],"prefix":"10.1186","volume":"20","author":[{"given":"Jeremy","family":"Kalicum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eris","family":"Nyx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Clare","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"642_CR1","unstructured":"BC Coroners Service. Unregulated Drugs Deaths\u2013\u20092023 Victoria, British Columbia: Government of British Columbia; 2024 [Available from: https:\/\/app.powerbi.com\/view?r=eyJrIjoiY2ZkZTgxODAtMmE5Mi00MzNjLTlkNDYtMjRhNjU4Nzk2NGZmIiwidCI6IjZmZGI1MjAwLTNkMGQtNGE4YS1iMDM2LWQzNjg1ZTM1OWFkYyJ9"},{"key":"642_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.drugpo.2020.102769","volume":"80","author":"A Ivsins","year":"2020","unstructured":"Ivsins A, Boyd J, Beletsky L, McNeil R. Tackling the overdose crisis: the role of safe supply. Int J Drug Policy. 2020;80:5.","journal-title":"Int J Drug Policy"},{"key":"642_CR3","unstructured":"BC Centre on Substance Use. Heroin compassion clubs: A cooperative model to reduce opioid overdose deaths & disrupt organized crime\u2019s role in fentanyl, money laundering & housing unaffordability. 2019."},{"issue":"5","key":"642_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.15288\/jsad.2020.81.556","volume":"81","author":"M Bonn","year":"2020","unstructured":"Bonn M, Palayew A, Bartlett S, Brothers TD, Touesnard N, Tyndall M. Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply. J Stud Alcohol Drug. 2020;81(5):556\u201360.","journal-title":"J Stud Alcohol Drug"},{"key":"642_CR5","doi-asserted-by":"crossref","unstructured":"Duthie K, Mathison E, Eyford H, Ghosh SM. Prescribing safe supply: ethical considerations for clinicians. J Med Ethics. 2022.","DOI":"10.1136\/jme-2021-108087"},{"key":"642_CR6","unstructured":"BC Coroners Service. BC coroners service death review panel: an urgent response to A continuing crisis. BC Coroners Service; 2023. pp. 1\u201345."},{"key":"642_CR7","unstructured":"BC Centre on Substance Use. Risk Mitigation in the context of dual public health emergencies. 2020."},{"key":"642_CR8","doi-asserted-by":"crossref","unstructured":"Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T, et al. It\u2019s Helped Me a Lot, Just Like to Stay Alive: a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada. Volume 98. Journal of Urban Health-Bulletin of the New York Academy of Medicine; 2021. pp. 59\u201369. 1.","DOI":"10.1007\/s11524-020-00489-9"},{"issue":"8","key":"642_CR9","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00213-020-05563-3","volume":"237","author":"VS Tardelli","year":"2020","unstructured":"Tardelli VS, Bisaga A, Arcadepani FB, Gerra G, Levin FR, Fidalgo TM. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. Psychopharmacology. 2020;237(8):2233\u201355.","journal-title":"Psychopharmacology"},{"issue":"1","key":"642_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","volume":"207","author":"J Strang","year":"2015","unstructured":"Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, et al. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. Br J Psychiatry. 2015;207(1):5\u201314.","journal-title":"Br J Psychiatry"},{"key":"642_CR11","doi-asserted-by":"crossref","unstructured":"Ledlie S, Garg R, Cheng C, Kolla G, Antoniou T, Bouck T et al. Prescribed safer opioid supply: A scoping review of the evidence 2024.","DOI":"10.1016\/j.drugpo.2024.104339"},{"issue":"3","key":"642_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.17269\/s41997-022-00736-3","volume":"114","author":"H Morris","year":"2023","unstructured":"Morris H, Bwala H, Wesley J, Hyshka E. Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces. Can J Public Health. 2023;114(3):484\u201392.","journal-title":"Can J Public Health"},{"issue":"1","key":"642_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-023-01331-x","volume":"19","author":"M Kurz","year":"2024","unstructured":"Kurz M, Guerra-Alejos BC, Min JE, Barker B, Pauly B, Urbanoski K, et al. Influence of physician networks on the implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia. Implement Sci. 2024;19(1):1\u201313.","journal-title":"Implement Sci"},{"key":"642_CR14","doi-asserted-by":"crossref","unstructured":"Kalicum J, Nyx E, Kennedy MC, Kerr T. The impact of an unsanctioned compassion club on non-fatal overdose. Int J Drug Policy. 2024.","DOI":"10.1016\/j.drugpo.2024.104330"},{"key":"642_CR15","unstructured":"Drug User Liberation Front. The DULF and VANDU evaluative compassion club and fulfilment centre framework: A strategic framework for preventing overdose deaths due to the unpredictable illicit drug supply 2023 [Available from: https:\/\/www.dulf.ca\/_files\/ugd\/fe034c_848afa78e1e947dfb03b5f962dd05a54.pdf?index=tru"},{"issue":"19","key":"642_CR16","doi-asserted-by":"publisher","first-page":"E674","DOI":"10.1503\/cmaj.211515","volume":"194","author":"S Klaire","year":"2022","unstructured":"Klaire S, Sutherland C, Kerr T, Kennedy MC. A low-barrier, flexible safe supply program to prevent deaths from overdose. Can Med Assoc J. 2022;194(19):E674\u20136.","journal-title":"Can Med Assoc J"},{"issue":"6","key":"642_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.280.6.547","volume":"280","author":"SA Strathdee","year":"1998","unstructured":"Strathdee SA, Palepu A, Cornelisse PGA, Yip B, O\u2019Shaughnessy MV, Montaner JSG, et al. Barriers to use of free antiretroviral therapy in injection drug users. Jama-Journal Am Med Association. 1998;280(6):547\u20139.","journal-title":"Jama-Journal Am Med Association"},{"key":"642_CR18","doi-asserted-by":"crossref","unstructured":"Lew B, Bodkin C, Lennox R, O\u2019Shea T, Wiwcharuk G, Turner S. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study. Harm Reduct J. 2022;19(1).","DOI":"10.1186\/s12954-022-00614-8"},{"key":"642_CR19","doi-asserted-by":"crossref","unstructured":"Nafeh F, Mbichila T, Bouck Z, Scheim A, Mitra S, Bonn M et al. A preliminary assessment of Short-Term social and substance Use-Related outcomes among clients of integrated safer opioid supply pilot programs in Toronto, Canada. Int J Mental Health Addict. 2023.","DOI":"10.1007\/s11469-023-01219-3"},{"key":"642_CR20","doi-asserted-by":"crossref","unstructured":"Slaunwhite A, Min JE, Palis H, Urbanoski K, Pauly B, Barker B et al. Effect of risk mitigation guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. Bmj-British Med J. 2024;384.","DOI":"10.1136\/bmj-2023-076336"},{"issue":"36","key":"642_CR21","doi-asserted-by":"publisher","first-page":"E1233","DOI":"10.1503\/cmaj.220892","volume":"194","author":"T Gomes","year":"2022","unstructured":"Gomes T, Kolla G, McCormack D, Sereda A, Kitchen S, Antoniou T. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario. Can Med Assoc J. 2022;194(36):E1233\u201342.","journal-title":"Can Med Assoc J"},{"issue":"19","key":"642_CR22","doi-asserted-by":"publisher","first-page":"E668","DOI":"10.1503\/cmaj.221550","volume":"195","author":"G Bardwell","year":"2023","unstructured":"Bardwell G, Ivsins A, Mansoor M, Nolan S, Kerr T. Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes. Can Med Assoc J. 2023;195(19):E668\u201376.","journal-title":"Can Med Assoc J"},{"key":"642_CR23","doi-asserted-by":"crossref","unstructured":"Haines M, O\u2019Byrne P. Safer opioid supply: qualitative program evaluation. Harm Reduct J. 2023;20(1).","DOI":"10.1186\/s12954-023-00776-z"},{"issue":"34","key":"642_CR24","doi-asserted-by":"publisher","first-page":"E986","DOI":"10.1503\/cmaj.201618","volume":"192","author":"M Tyndall","year":"2020","unstructured":"Tyndall M. A safer drug supply: a pragmatic and ethical response to the overdose crisis. Can Med Assoc J. 2020;192(34):E986\u20137.","journal-title":"Can Med Assoc J"},{"key":"642_CR25","unstructured":"BC Coroners Service. BC coroners service death review panel: A review of illicit drug toxicity deaths. BC Coroners Service; 2022. pp. 1\u201360."},{"key":"642_CR26","doi-asserted-by":"crossref","unstructured":"Brothers TD, Leaman M, Bonn M, Lewer D, Atkinson J, Fraser J et al. Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness. Drug Alcohol Depend. 2022;235.","DOI":"10.1016\/j.drugalcdep.2022.109440"},{"key":"642_CR27","doi-asserted-by":"crossref","unstructured":"Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T et al. Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study. Drug Alcohol Depend. 2020;216.","DOI":"10.1016\/j.drugalcdep.2020.108202"},{"issue":"9","key":"642_CR28","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/add.16200","volume":"118","author":"C Bharat","year":"2023","unstructured":"Bharat C, Webb P, Wilkinson Z, McKetin R, Grebely J, Farrell M, et al. Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis. Addiction. 2023;118(9):1624\u201348.","journal-title":"Addiction"},{"issue":"3","key":"642_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253\u201363.","journal-title":"Drug Alcohol Depend"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-025-00642-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-025-00642-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-025-00642-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:58:45Z","timestamp":1741597125000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-025-00642-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1186\/s13011-025-00642-0","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for secondary analysis of the data was obtained from the University of British Columbia\u2019s Behavioural Research Ethics Board (H23-02497). Informed consent was obtained from all participants prior to every survey administration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"CRediT Authorship and Contribution Statements.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Jeremy Kalicum: Study Design - Writing \u2013 review & editing, Writing \u2013 original draft, Conceptualization, Data analysis. Eris Nyx: Study Design - Writing reviewing & editing, Conceptualization. Thomas Kerr: Study Design - Writing \u2013 reviewing and editing. Supervision. Methodology, Conceptualization. Mary Clare Kennedy: Writing \u2013 review & editing,","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors have no competing interests to declare.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"11"}}